Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TRANSPORTATION Transportation Secretary Norman Mineta warns Amtrak that federal funds may not be available to bail…
Op-Eds
Infant Formula Ambush by Henry I. Miller
Self-styled public-health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. Activists'…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SPAM E-MAIL Spam “zombies”—computers that are hijacked to send out a spammer’s unwanted email messages—get…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY A small group of U.S. House members is proposing new federal rules for disposal…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CIVIL LIBERTIES The Senate Select Committee on Intelligence begins debate over whether to renew…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ECONOMIC LIBERTY The union campaign against Wal-Mart expands in the Washington,…